Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

Summary

This protocol will evaluate the efficacy of obatoclax in older patients with previously untreated AML.

Timeline

Start

2008-04

Primary completion

2009-08

Completion

2009-12

Publications

• Schimmer AD, Raza A, Carter TH, Claxton D, Erba H, DeAngelo DJ, Tallman MS, Goard C, Borthakur G. A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia. PLoS One. 2014 Oct 6;9(10):e108694. doi: 10.1371/journal.pone.0108694. eCollection 2014.

Drugs

Indications